SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 114 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $142,000 | -65.5% | 11,664 | -54.8% | 0.00% | -66.7% |
Q4 2015 | $411,000 | -25.5% | 25,829 | +13.8% | 0.01% | -25.0% |
Q2 2015 | $552,000 | +99.3% | 22,692 | +90.7% | 0.02% | +77.8% |
Q1 2015 | $277,000 | -59.0% | 11,900 | -55.8% | 0.01% | -60.9% |
Q4 2014 | $675,000 | +70.9% | 26,900 | +111.8% | 0.02% | +64.3% |
Q3 2014 | $395,000 | -16.1% | 12,700 | -30.2% | 0.01% | -22.2% |
Q2 2014 | $471,000 | – | 18,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |